Trial Outcomes & Findings for Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women (NCT NCT01866917)
NCT ID: NCT01866917
Last Updated: 2020-08-20
Results Overview
Pain assessments by verbal numerical pain score (NPS) at 0, 1 and 2 hours prior to discharge in the Post Anesthesia Care Unit. The 10 point NPS scale ranges from 0-10 with 0 being equivalent to no pain and a value of 10 being equivalent to the worst pain imaginable
TERMINATED
PHASE1/PHASE2
35 participants
0, 1, and 2 hours
2020-08-20
Participant Flow
Participant milestones
| Measure |
Transversus Abdominal Plane
Ropivicaine 0.5% 20cc injectate bilaterally
Group B
|
Saline
Normal saline 20cc injectate bilaterally
Group A
|
|---|---|---|
|
Overall Study
STARTED
|
17
|
18
|
|
Overall Study
COMPLETED
|
13
|
12
|
|
Overall Study
NOT COMPLETED
|
4
|
6
|
Reasons for withdrawal
| Measure |
Transversus Abdominal Plane
Ropivicaine 0.5% 20cc injectate bilaterally
Group B
|
Saline
Normal saline 20cc injectate bilaterally
Group A
|
|---|---|---|
|
Overall Study
Pharmacist stopped dispensing treatment
|
4
|
6
|
Baseline Characteristics
Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women
Baseline characteristics by cohort
| Measure |
Transversus Abdominal Plane (Drug B)
n=13 Participants
Ropivicaine 0.5% 20cc injectate bilaterally
|
Saline (Drug A)
n=12 Participants
Normal saline 20cc injectate bilaterally
|
Total
n=25 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
45.6 years
STANDARD_DEVIATION 7.97 • n=5 Participants
|
42.0 years
STANDARD_DEVIATION 7.97 • n=7 Participants
|
43.8 years
STANDARD_DEVIATION 7.97 • n=5 Participants
|
|
Sex: Female, Male
Female
|
13 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
25 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 0, 1, and 2 hoursPopulation: There were 13 participants receiving the Transversus Abdominis Plane TAP (Group B) and 12 participants receiving the placebo Saline (Group A).
Pain assessments by verbal numerical pain score (NPS) at 0, 1 and 2 hours prior to discharge in the Post Anesthesia Care Unit. The 10 point NPS scale ranges from 0-10 with 0 being equivalent to no pain and a value of 10 being equivalent to the worst pain imaginable
Outcome measures
| Measure |
Transversus Abdominis Plane (TAP) Group B
n=13 Participants
Ropivicaine 0.5% 20cc IV bilaterally
|
Saline Group A
n=12 Participants
Normal saline 20cc IV bilaterally
|
|---|---|---|
|
Postoperative Numeric Pain Rating Score (NPRS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)
0 hour
|
0 score on a scale
Interval 0.0 to 8.0
|
5.5 score on a scale
Interval 0.0 to 9.0
|
|
Postoperative Numeric Pain Rating Score (NPRS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)
1 hour
|
3 score on a scale
Interval 0.0 to 8.0
|
3.5 score on a scale
Interval 0.0 to 5.0
|
|
Postoperative Numeric Pain Rating Score (NPRS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)
2 hours
|
3 score on a scale
Interval 0.0 to 6.0
|
4.5 score on a scale
Interval 0.0 to 5.0
|
PRIMARY outcome
Timeframe: 4hrs, 8hrs, 12hrs, and 24hrs.Pain assessments by verbal numerical pain score (NPS) at 4, 8, 12 and 24 hours prior to discharge in the Post Anesthesia Care Unit. The 10 point NPS scale ranges from 0-10 with 0 being equivalent to no pain and a value of 10 being equivalent to the worst pain imaginable
Outcome measures
| Measure |
Transversus Abdominis Plane (TAP) Group B
n=13 Participants
Ropivicaine 0.5% 20cc IV bilaterally
|
Saline Group A
n=12 Participants
Normal saline 20cc IV bilaterally
|
|---|---|---|
|
Postoperative Numeric Pain Score (NPS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)
4 hours
|
0 score on a scale
Interval 0.0 to 7.0
|
5.5 score on a scale
Interval 0.0 to 6.0
|
|
Postoperative Numeric Pain Score (NPS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)
8 hours
|
1 score on a scale
Interval 0.0 to 5.0
|
2 score on a scale
Interval 0.0 to 6.0
|
|
Postoperative Numeric Pain Score (NPS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)
12 hours
|
2 score on a scale
Interval 0.0 to 6.0
|
3 score on a scale
Interval 0.0 to 5.0
|
|
Postoperative Numeric Pain Score (NPS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)
24 hours
|
3 score on a scale
Interval 0.0 to 6.0
|
1.5 score on a scale
Interval 0.0 to 7.0
|
Adverse Events
Group B (TAP Block)
Group A (Saline)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place